Studien | Der Arzneimittelbrief

ARNICFH

The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF

ARNIMEMS-HFpEF

Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

ARO

Analyzing data, Recognizing excellence and Optimmizing outcome CDK research initiative

AROAAT-2002

Study of ARO-AAT in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)

ARON

Antibiotic prescribing rate after optimal near-patient C-reactive protein testing in acutely ill children presenting to ambulatory care

ARON-1

International Multicentric Study ARON-1. First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma

ARPEGGIO

Effect of Rimonabant on Glycemic Control in Insulin-Treated Type 2 Diabetes

ARREST

A Randomized tRial of Expedited transfer to a cardiac arrest center for non-ST elevation out-of-hospital cardiac arrest

ARREST

Adjunctive rifampicin for Staphylococcus aureus bacteraemia

ARREST

Amiodarone in out-of-hospital Resuscitation of REfractory Sustained ventricular Tachyarrhythmia

ARREST

Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest

ARREST

Rationale and methods of the Advanced R2Eperfusion STrategies for refractory cardiac arrest

ARREST-AF

Aggressive Risk factor REduction STudy for Atrial Fibrillation

ARREVE

Terminal Weaning of Mechanical Ventilation or Extubation in Anticipation of Death in the Intensive Care Unit

ARRISA-UK

At-Risk Registers In Severe Asthma-United Kingdom

ARRIVE

A clinical risk score for prediction of stent thrombosis

ARRIVE

A Randomized Trial of Induction Versus Expectant Management - Trial on Elective Induction and Obstetric Outcomes in Term Nulliparous Patients

ARRIVE

Aspirin to Reduce Risk of Initial Vascular Events

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

ARROW

Absolute Risk ReductiOn in systematic revieWs

ARROW

AntiRetroviral Research fOr Watoto

ARROW

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

ARROW

Selonsertib in Adults With Pulmonary Arterial Hypertension

ART

AntiRetroviral Therapy

ART

Anturane Reinfarction Trial

ART

Arterial Revascularisation Trial

ART

Feasibility and impact of cardiovascular absolute risk assessment in Australian general practice

ART-CAF

Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients With Device-Detected Subclinical Atrial Fibrillation

ART-CC

Antiretroviral Therapy Cohort Collaboration

ART-DECO

A randomised multicentre accelerated radiotherapy study of dose escalated intensity modulated radiotherapy versus standard dose intensity modulated radiotherapy in patients receiving treatment for locally advanced laryngeal and hypopharyngeal cancers

ART-LINC

Antiretroviral Therapy in Lower INcome Countries

ART-PRO

Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine

ART-TTH

Acupuncture Randomised Trial in Tension-type Headache

ARTE

Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following

ARTEMIS

A Reduction in Time with Electronic Monitoring In Stroke

ARTEMIS

AR101 Trial in Europe Measuring Oral Immunotherapy Success in peanut-allergic children

ARTEMIS

ARixtra for ThromboEmbolism prevention in a Medical Indications Study

ARTemis

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer

ARTEMIS

Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction

ARTEMIS

International Ambulatory Blood Pressure Registry: Telemonitoring of Hypertension and Cardiovascular Risk Project

Artemis

Performance of a new, structured diagnostic algorithm for suspected pulmonary embolism in pregnant patients

ARTEMIS

Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

ARTEMIS-CTONG1509

Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC

ARTEMIS-DM

Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin

ARTEMIS-IGAN

Study of the Safety and Efficacy of OMS721 (Narsoplimab) in Patients With Immunoglobulin A (IgA) Nephropathy

ARTEMIS-UC

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

ARTESiA

Apixaban for the reduction of Thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation

ARTFL

Advancing Research and Treatment for Frontotemporal Lobar Degeneration

ARTICO

Aortic valve Replacement compared to Transcatheter Implant and its relationship with COgnitive Impairment

ARTIS

Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke

ARTIS

Anti-Rheumatic Therapy in Sweden

ARTISAN

Acute Rehabilitation following Traumatic anterior shoulder dISlocAtioN

ARTIST

Angioplasty versus Rotational atherectomy for Treatment of diffuse In-Stent restenosis Trial

ARTISTIC

A Randomised Trial In Screening To Improve Cytology

ARTISTIC

AngioRad Radiation Therapy for In-STent restenosis Intracoronary